Neurology 2001;56:82-86
© 2001 American Academy of Neurology
Articles
Sensory Guillain–Barré syndrome
Shin J. Oh, MD;,
Chris LaGanke, MD; and
Gwen C. Claussen, MD
From the Department of Neurology, University of Alabama at Birmingham, and the Veterans Affairs Medical Center, Birmingham, AL.
Address correspondence and reprint requests to Dr. Shin J. Oh, Department of Neurology, University of Alabama at Birmingham, UAB Station, Birmingham, AL 35294; e-mail: shinjoh{at}uab.edu
Objective: To report eight cases of sensory Guillain–Barré syndrome (GBS). Background: The concept of sensory equivalent to ascending paralysis of GBS was raised in 1958, and the diagnostic criteria for a sensory loss and areflexia variant of GBS were proposed in 1981. However, clinical cases meeting these criteria have been relatively scarce. Methods: During a 13-year period between 1986 and 1999, the authors collected eight cases of an acute sensory demyelinating neuropathy that met most of the proposed diagnostic criteria of a sensory variant of GBS. Results: In all patients, sensory neuropathy was sudden at onset and peaked to maximal deficit within 4 weeks. In five (63%) cases, there was an antecedent viral illness. All patients had objective sensory loss and diminished or absent reflexes. None showed any muscle weakness. In all four patients in whom the spinal fluid was examined during the first 4 weeks, there was albuminocytologic dissociation. All of the patients had electrophysiologic evidence of demyelination in at least two nerves. Demyelination was demonstrated in motor nerve conduction in seven patients and in sensory nerve conduction in one, indicating that motor nerve conduction studies were the key for the diagnosis of demyelinating neuropathy. All patients had sensory nerve conduction abnormalities in at least one nerve. Three patients responded to immunotherapies. All had a favorable outcome, with a monophasic course of disease and no sign of relapse. Conclusion: The current study confirms the existence of sensory GBS.
This article has been cited by other articles:
|
|
|
|
 
J Kalita, U K Misra, and M Das
Neurophysiological criteria in the diagnosis of different clinical types of Guillain-Barre syndrome
J. Neurol. Neurosurg. Psychiatry,
March 1, 2008;
79(3):
289 - 293.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Paticoff, A. Valovska, S. S. Nedeljkovic, and A. L. Oaklander
Defining a Treatable Cause of Erythromelalgia: Acute Adolescent Autoimmune Small-Fiber Axonopathy
Anesth. Analg.,
February 1, 2007;
104(2):
438 - 441.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S.-S. Lee and S.-H. Lee
Does sensory Guillain-Barre syndrome exist without any abnormalities in motor nerve conduction?
Neurology,
March 28, 2006;
66(6):
947 - 948.
[Full Text]
[PDF]
|
|
|
|
|
|
|
P Gonzalez-Alegre
Severe interscapular pain and increased creatine kinase activity: the answer was in the ankles
Emerg. Med. J.,
February 1, 2005;
22(2):
152 - 153.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C.-L. Pan, T.-J. Tseng, Y.-H. Lin, M.-C. Chiang, W.-M. Lin, and S.-T. Hsieh
Cutaneous innervation in Guillain-Barre syndrome: pathology and clinical correlations
Brain,
February 1, 2003;
126(2):
386 - 397.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
U Seneviratne and S Gunasekera
Acute small fibre sensory neuropathy: another variant of Guillain-Barre syndrome?
J. Neurol. Neurosurg. Psychiatry,
April 1, 2002;
72(4):
540 - 542.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P MADDISON, M ODAKA, and N YUKI
Anti-GQ1b IgG antibody syndrome without ophthalmoplegia: clinical and immunological features
J. Neurol. Neurosurg. Psychiatry,
August 1, 2001;
71(2):
282 - 283.
[Full Text]
|
|
|
|
|
|
|
Sensory Guillain-Barre Syndrome: Does It Exist?
Journal Watch Neurology,
March 28, 2001;
2001(328):
1 - 1.
[Full Text]
|
|
|
|
